https://www.selleckchem.com/pr....oducts/alflutinib-as
Moderate disability at first visit was associated with faster progression to severe disability. Mean estimated range of disease onset was between 4.3 to 9.9 years prior to first presentation. Majority of PPMS patients progressed to moderate disability within 5-years and to severe disability within 15-years from first presentation. Clinical disability progression trajectories can help treatment-related decisions. Majority of PPMS patients progressed to moderate disability within 5-years and to severe disability within
Like
Comment
Share
